Catalent Pharma Solutions, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 160S Pharma Drive, Morrisville, North Carolina (NC) 27560, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 1000110912 · DUNS 119332987
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-05-22
- VAIBlood and Blood Products2024-05-24
- VAIDrug Quality Assurance2022-12-15
- OAIDrug Quality Assurance2020-09-28
- NAIDrug Quality Assurance2019-12-20
- NAIDrug Quality Assurance2019-03-04
- NAIBioresearch Monitoring2019-02-01
- VAIDrug Quality Assurance2017-05-19
- VAIDrug Quality Assurance2015-03-20
- NAIDrug Quality Assurance2013-02-14
- NAIDrug Quality Assurance2010-11-11
- NAIDrug Quality Assurance2009-11-18
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- anagrelide hydrochlorideTakeda Pharmaceuticals America, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.